In particular, IL10-MSCs treated mice had a more decrease in insulin resistance compared with MSCs treated mice, similar to NCD mice, indicating IL10-MSCs could significantly improve insulin sensitivity in HFD mice, close to basal level. The gene discussed is INS; the disease is Insulin resistance.